about
A review on vitamin d deficiency treatment in pediatric patientsImpact of antiepileptic drugs on bone health: Need for monitoring, treatment, and prevention strategiesDietary Intakes and Nutritional Issues in Neurologically Impaired ChildrenAnticonvulsant drugs and hematological disease.Antiepileptic drug interactions - principles and clinical implications.Antiepileptic medications increase osteoporosis risk in male fabry patients: bone mineral density in an Australian cohort.Developmental enamel defects in children prenatally exposed to anti-epileptic drugs.The impact of the use of antiepileptic drugs on the growth of childrenNormal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs.Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis.Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice.Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.Antiepileptics and bone health.Relationship of caffeine dosing with serum alkaline phosphatase levels in extremely low-birth-weight infantsBrains, bones, and aging: psychotropic medications and bone health among older adults.Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with EpilepsyShould orthopedic surgeons consider the effects of gabapentin administration on bone healing while treating a long bone fracture: experimental study in a rat model.Update in pediatrics: focus on fat-soluble vitamins.Pharmacotherapy for children and adolescents with epilepsy.Polypharmacy and food-drug interactions among older persons: a review.Epilepsy and vitamin D.The problem of osteoporosis in epileptic patients taking antiepileptic drugs.Adverse skeletal effects of drugs - beyond Glucocorticoids.Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy.Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.Variation in antiepileptic drug adherence among older patients with new-onset epilepsy.The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.Side-Effects of Convulsive Seizures and Anti-Seizure Therapy on Bone in a Rat Model of Epilepsy.Low levels of vitamin D poorly responsive to daylight exposure in patients with therapy-resistant schizophrenia.Bone mineral density in ambulatory children with epilepsy.Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.Evaluation of bone health among epileptic patients using biochemical markers and DEXA scan: an Egyptian study
P2860
Q26863762-84C781F6-8368-47D6-8FE3-01C2FDEF5F75Q28074005-734D9C48-630B-440C-A455-A361E60A965DQ28087116-40583CF3-45B9-4F4F-837C-9192DEE1EF5EQ33413868-FBB820EB-8CA3-487D-97F9-561925DD12CAQ34402188-4A6E9A05-A297-4568-A785-220D200089D7Q34560222-43F1CDE6-3275-401C-A9B3-0F62DD6B0C0CQ34631756-8C25E068-4589-4810-B39C-BC7A766CC427Q35071970-25F58BE6-D6C0-4335-B6BC-7343C3642A90Q35165033-DA4F83E6-E4AB-4BDE-A358-B6D53D9477C9Q35864841-EBF2095F-1020-4D0B-9DA6-ED1616EE87A4Q35895011-E5315604-4CE3-4DB2-9F2B-C57674AF70F4Q35924416-7E7A9B36-1A96-47C7-94F8-3E98E22B692EQ36059549-29A2A489-46B2-4E47-871E-A2EA159694CCQ36191089-A16545B2-7DB7-4184-B4B8-ACAC8DF5527FQ36427958-5804D099-37CA-40BF-8481-9B97B3E8A339Q36514350-78EF0CB3-DC93-4F6F-8F3D-CA213D291387Q37383753-CF5F6215-38A0-4BA5-83D9-7E534AA32C7FQ37779424-76986501-AEF5-489F-BAC5-274D6DB06B12Q37826193-D3B350C8-C246-4049-8529-1F102B5AE80DQ38060181-B0403279-C3F5-43CA-8813-F2D820BCAF12Q38142332-A42059BC-CAF6-4124-9EEF-4B8E9015E054Q38211406-C31FB8B5-9ED3-4DD4-A49A-69123800E28DQ38231316-7DEEB502-39B2-4A09-8461-317CD2353EC7Q38310689-E44744DF-AFBD-4D8F-8F65-61A0FFDFC332Q39030320-A8E55A45-2CD5-447D-BCAC-ABD54AA9EF01Q42838449-7B0C1C62-12D4-4FDC-9A39-9A512A068285Q46293491-411EABAE-7463-4EC8-9B4D-4323371DC946Q50108681-9E3F924F-2505-4380-87E3-583ECFA38043Q50536233-CE2B0477-B0DB-4CC8-A2C2-EF338022AC5CQ51059654-2387CC17-12D6-4FAF-9B09-890D8F1F70D8Q53301415-F0C153D5-9A9D-49D6-B0F4-74A77A6F4208Q56604475-12D7CB61-ECEA-4AF8-AA25-3EF1C2AACD42
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bone and calcium metabolism and antiepileptic drugs.
@ast
Bone and calcium metabolism and antiepileptic drugs.
@en
Bone and calcium metabolism and antiepileptic drugs.
@nl
type
label
Bone and calcium metabolism and antiepileptic drugs.
@ast
Bone and calcium metabolism and antiepileptic drugs.
@en
Bone and calcium metabolism and antiepileptic drugs.
@nl
prefLabel
Bone and calcium metabolism and antiepileptic drugs.
@ast
Bone and calcium metabolism and antiepileptic drugs.
@en
Bone and calcium metabolism and antiepileptic drugs.
@nl
P2093
P1476
Bone and calcium metabolism and antiepileptic drugs
@en
P2093
Alberto Verrotti
Angelika Mohn
Francesco Chiarelli
Pasquale Parisi
P356
10.1016/J.CLINEURO.2009.10.011
P577
2009-11-12T00:00:00Z